Webinar On-Demand: Shift the Paradigm to Centrifuge-less Immuno-staining of Cells for Superior Viability, Recovery & Data

Insights into adult atopic dermatitis heterogeneity derived from circulating biomarker profiling in patients with moderate-to-severe disease

Scientists at Eli Lilly were characterizing circulatory inflammatory profiles and underlying systemic disease heterogeneity within atopic dermatitis (AD) patients. The multiplexing study of several pro-inflammatory mediators distinguished between baseline disease severities, demonstrated by greater EASI, SCORAD Index, Itch NRS and DLQI scores. DropArray Technology provided a 5uL- sample volume workflow, which complies towards extended cytokine clusters and comparisons. With sample miniaturization, the performance is capable of depicting an output of scaled and centralized cytokine data per marker across donors. This process led to finding baseline cytokines or chemokines (e.g. Th2/Th22-related biomarkers ) that offer objective and consistent outcome measures of disease severity

Subscribe to our newsletter

Get updates about upcoming webinar technical application information and product announcements when you subscribe to the Curiox newsletter.